Earlier epoetin labelling changes expanded by US FDA
- 8 Downloads
KeywordsChronic Renal Failure Zidovudine Darbepoetin Alfa Boxed Warning Chronic Renal Failure Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.FDA.FDA Strengthens Boxed Warnings, Approves Other Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs). Media Release: 8 Nov 2007. Available from: URL: http://www.fda.gov
© Adis International limited or Adis Data Information BV 2007